Literature DB >> 31719922

Cell Subtypes Within the Liver Microenvironment Differentially Interact with Lipid Nanoparticles.

Cory D Sago1,2, Brandon R Krupczak1,2, Melissa P Lokugamage1, Zubao Gan1, James E Dahlman1.   

Abstract

INTRODUCTION: Lipid nanoparticles (LNPs) tend to accumulate in the liver due to physiological factors. Whereas the biological mechanisms that promote LNP delivery to hepatocytes have been reported, the mechanisms that promote delivery to other cell types within the liver microenvironment are poorly understood. Single cell profiling studies have recently identified subsets of Kupffer cells and hepatic endothelial cells with distinct gene expression patterns and biological phenotypes; we hypothesized these subtypes would differentially interact with nanoparticles.
METHODS: To test the hypothesis, we quantified nucleic acid (i) biodistribution and (ii) functional mRNA delivery within the liver microenvironment using two clinically relevant LNPs in vivo.
RESULTS: We found that these LNPs distribute nucleic acids distribute to Kupffer cells and liver endothelial cells as efficiently as they distribute to hepatocytes, yet result in more functional mRNA delivery to endothelial cells. Additionally, we found these LNPs differentially accumulate in Kupffer and endothelial cell subsets.
CONCLUSIONS: These data suggest subsets of liver microenvironmental cells can differentially interact with nanoparticles in vivo, thereby altering LNP delivery. More generally, the data suggest that nucleic acid biodistribution is not sufficient to predict functional nucleic acid delivery in vivo. © Biomedical Engineering Society 2019.

Entities:  

Keywords:  Drug delivery; Endothelial cell; Kupffer cell; Microenvironment; siRNA

Year:  2019        PMID: 31719922      PMCID: PMC6816632          DOI: 10.1007/s12195-019-00573-4

Source DB:  PubMed          Journal:  Cell Mol Bioeng        ISSN: 1865-5025            Impact factor:   2.321


  30 in total

1.  Phenotype Determines Nanoparticle Uptake by Human Macrophages from Liver and Blood.

Authors:  Sonya A MacParland; Kim M Tsoi; Ben Ouyang; Xue-Zhong Ma; Justin Manuel; Ali Fawaz; Mario A Ostrowski; Benjamin A Alman; Anton Zilman; Warren C W Chan; Ian D McGilvray
Journal:  ACS Nano       Date:  2017-01-17       Impact factor: 15.881

2.  A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates.

Authors:  Staci Sabnis; E Sathyajith Kumarasinghe; Timothy Salerno; Cosmin Mihai; Tatiana Ketova; Joseph J Senn; Andy Lynn; Alex Bulychev; Iain McFadyen; Joyce Chan; Örn Almarsson; Matthew G Stanton; Kerry E Benenato
Journal:  Mol Ther       Date:  2018-03-14       Impact factor: 11.454

3.  Nanoparticles Containing Oxidized Cholesterol Deliver mRNA to the Liver Microenvironment at Clinically Relevant Doses.

Authors:  Kalina Paunovska; Alejandro J Da Silva Sanchez; Cory D Sago; Zubao Gan; Melissa P Lokugamage; Fatima Z Islam; Sujay Kalathoor; Brandon R Krupczak; James E Dahlman
Journal:  Adv Mater       Date:  2019-02-12       Impact factor: 30.849

4.  Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq.

Authors:  Amit Zeisel; Ana B Muñoz-Manchado; Simone Codeluppi; Peter Lönnerberg; Gioele La Manno; Anna Juréus; Sueli Marques; Hermany Munguba; Liqun He; Christer Betsholtz; Charlotte Rolny; Gonçalo Castelo-Branco; Jens Hjerling-Leffler; Sten Linnarsson
Journal:  Science       Date:  2015-02-19       Impact factor: 47.728

5.  Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing.

Authors:  Hao Yin; Chun-Qing Song; Sneha Suresh; Qiongqiong Wu; Stephen Walsh; Luke Hyunsik Rhym; Esther Mintzer; Mehmet Fatih Bolukbasi; Lihua Julie Zhu; Kevin Kauffman; Haiwei Mou; Alicia Oberholzer; Junmei Ding; Suet-Yan Kwan; Roman L Bogorad; Timofei Zatsepin; Victor Koteliansky; Scot A Wolfe; Wen Xue; Robert Langer; Daniel G Anderson
Journal:  Nat Biotechnol       Date:  2017-11-13       Impact factor: 54.908

6.  Modified mRNA Vaccines Protect against Zika Virus Infection.

Authors:  Justin M Richner; Sunny Himansu; Kimberly A Dowd; Scott L Butler; Vanessa Salazar; Julie M Fox; Justin G Julander; William W Tang; Sujan Shresta; Theodore C Pierson; Giuseppe Ciaramella; Michael S Diamond
Journal:  Cell       Date:  2017-02-17       Impact factor: 41.582

7.  Analyzing 2000 in Vivo Drug Delivery Data Points Reveals Cholesterol Structure Impacts Nanoparticle Delivery.

Authors:  Kalina Paunovska; Carmen J Gil; Melissa P Lokugamage; Cory D Sago; Manaka Sato; Gwyn N Lando; Marielena Gamboa Castro; Anton V Bryksin; James E Dahlman
Journal:  ACS Nano       Date:  2018-07-20       Impact factor: 15.881

8.  Barcoding chemical modifications into nucleic acids improves drug stability in vivo.

Authors:  Cory D Sago; Sujay Kalathoor; Jordan P Fitzgerald; Gwyneth N Lando; Naima Djeddar; Anton V Bryksin; James E Dahlman
Journal:  J Mater Chem B       Date:  2018-08-28       Impact factor: 6.331

9.  High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing.

Authors:  Cory D Sago; Melissa P Lokugamage; Kalina Paunovska; Daryll A Vanover; Christopher M Monaco; Nirav N Shah; Marielena Gamboa Castro; Shannon E Anderson; Tobi G Rudoltz; Gwyneth N Lando; Pooja Munnilal Tiwari; Jonathan L Kirschman; Nick Willett; Young C Jang; Philip J Santangelo; Anton V Bryksin; James E Dahlman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

10.  Single-cell RNA-seq reveals dynamic paracrine control of cellular variation.

Authors:  Alex K Shalek; Rahul Satija; Joe Shuga; John J Trombetta; Dave Gennert; Diana Lu; Peilin Chen; Rona S Gertner; Jellert T Gaublomme; Nir Yosef; Schraga Schwartz; Brian Fowler; Suzanne Weaver; Jing Wang; Xiaohui Wang; Ruihua Ding; Raktima Raychowdhury; Nir Friedman; Nir Hacohen; Hongkun Park; Andrew P May; Aviv Regev
Journal:  Nature       Date:  2014-06-11       Impact factor: 49.962

View more
  10 in total

1.  Mild Innate Immune Activation Overrides Efficient Nanoparticle-Mediated RNA Delivery.

Authors:  Melissa P Lokugamage; Zubao Gan; Chiara Zurla; Joel Levin; Fatima Z Islam; Sujay Kalathoor; Manaka Sato; Cory D Sago; Philip J Santangelo; James E Dahlman
Journal:  Adv Mater       Date:  2019-11-19       Impact factor: 30.849

Review 2.  Understanding Nanomaterial-Liver Interactions to Facilitate the Development of Safer Nanoapplications.

Authors:  Jiulong Li; Chunying Chen; Tian Xia
Journal:  Adv Mater       Date:  2022-02-03       Impact factor: 32.086

3.  Increased PIP3 activity blocks nanoparticle mRNA delivery.

Authors:  Kalina Paunovska; Alejandro Da Silva Sanchez; Matthew T Foster; David Loughrey; Emmeline L Blanchard; Fatima Z Islam; Zubao Gan; Athanasios Mantalaris; Philip J Santangelo; James E Dahlman
Journal:  Sci Adv       Date:  2020-07-22       Impact factor: 14.136

Review 4.  Lipid nanoparticle technology for therapeutic gene regulation in the liver.

Authors:  Dominik Witzigmann; Jayesh A Kulkarni; Jerry Leung; Sam Chen; Pieter R Cullis; Roy van der Meel
Journal:  Adv Drug Deliv Rev       Date:  2020-07-02       Impact factor: 15.470

5.  Nanoparticles containing constrained phospholipids deliver mRNA to liver immune cells in vivo without targeting ligands.

Authors:  Zubao Gan; Melissa P Lokugamage; Marine Z C Hatit; David Loughrey; Kalina Paunovska; Manaka Sato; Ana Cristian; James E Dahlman
Journal:  Bioeng Transl Med       Date:  2020-05-27

Review 6.  Application of lipid-based nanoparticles in cancer immunotherapy.

Authors:  Zhongkun Zhang; Siyu Yao; Yingwen Hu; Xiaobin Zhao; Robert J Lee
Journal:  Front Immunol       Date:  2022-08-08       Impact factor: 8.786

7.  Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial System.

Authors:  Roy Pattipeiluhu; Gabriela Arias-Alpizar; Genc Basha; Karen Y T Chan; Jeroen Bussmann; Thomas H Sharp; Mohammad-Amin Moradi; Nico Sommerdijk; Edward N Harris; Pieter R Cullis; Alexander Kros; Dominik Witzigmann; Frederick Campbell
Journal:  Adv Mater       Date:  2022-03-10       Impact factor: 32.086

Review 8.  Directing the Way-Receptor and Chemical Targeting Strategies for Nucleic Acid Delivery.

Authors:  Ricarda Carolin Steffens; Ernst Wagner
Journal:  Pharm Res       Date:  2022-09-15       Impact factor: 4.580

Review 9.  Nucleic Acid-Based Approaches for Tumor Therapy.

Authors:  Simone Hager; Frederic Julien Fittler; Ernst Wagner; Matthias Bros
Journal:  Cells       Date:  2020-09-09       Impact factor: 6.600

Review 10.  Intracellular Routing and Recognition of Lipid-Based mRNA Nanoparticles.

Authors:  Christophe Delehedde; Luc Even; Patrick Midoux; Chantal Pichon; Federico Perche
Journal:  Pharmaceutics       Date:  2021-06-24       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.